生命科学资讯

Appointments and advancements for Jan. 23, 2026

FDA tackles BP wearables in new draft guidance

AI identifies pregnancies at risk of spontaneous pre-term birth

Legislation seeks to guard NIH from politicization

Researchers develop Revoice for stroke patients

Researchers develop 3,3-dimethyl-2-oxoindiline STING inhibitors

Gene therapy induces biological pacemakers in heart block models

Novel TTK inhibitor for TNBC therapy

Targeting DUX4 with improves muscle function in FSHD models

Janux’s tumor-activated platform draws BMS in potential $850M deal

Appointments and advancements for Jan. 22, 2026

Financings for Jan. 22, 2026

Other news to note for Jan. 22, 2026

Regulatory actions for Jan. 22, 2026

Corcept’s relacorilant could reach $2.1B ovarian cancer market

Rezubio Pharmaceuticals discloses new drug conjugates to treat fibrosis

Lunan New Time Biotechnical reports new camptothecin derivatives and their ADCs

Shanghai Qingrun Pharmaceutical Technology synthesizes new GTPase KRAS mutant inhibitors

Beyang Therapeutics discovers salts of VEGFR inhibitors

Sunshine Lake Pharma divulges new PKMYT1 inhibitors